Alert detail
FDA Approval: ROCURONIUM (ROCURONIUM BROMIDE) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA217472Specialty: Multi-specialtyAdded: 7/18/2026Effective: 2025-06-09billing update
What changed
New manufacturer rocuronium IV; verify NDC maps to existing J-code.
Who’s affected: Multi-specialty billing teams · Effective: 2025-06-09
Affected codes
CodesJ2704
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 1 billing code.
Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.
Not ready to subscribe?
Get the free weekly reimbursement brief for Multi-specialty— the week’s changes and deadlines, delivered to your inbox. No account required.